dynamic: ctdna guiding adjuvant chemotherapy in stage ii colon cancer
Published 2 years ago • 536 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
3:48
using ctdna to guide adjuvant therapy in stage ii colorectal cancer
-
3:17
highlights on adjuvant chemotherapy of stage ii colon cancer: the dynamic trial
-
4:31
cobra: ctdna to help decide which patients with colon cancer will benefit from adjuvant chemotherapy
-
1:19
assessing the role of adjuvant chemotherapy in stage iii dmmr colon cancer
-
35:30
dynamic - circulating tumor dna to decide adjuvant chemo in stage ii colon cancer | level - hard
-
0:45
the emerging role of ctdna in cancer diagnostics
-
2:43
real-world impact of adjuvant chemotherapy on patients with pt4n0 colon cancer
-
2:30
how can we use ctdna to improve adjuvant treatment for colon cancer?
-
3:29
ctdna and cfdna : prognostic value in the neoadjuvant setting of colon cancer
-
5:33
circulating tumour dna analysis can help identify the need for ct in stage ii colon cancer
-
2:13
ongoing clinical trials on using ctdna results to guide gi cancer management
-
3:41
circulate-us: investigating the use of ctdna to detect mrd
-
34:01
episode 101: colorectal cancer series, pt. 3 - adjuvant therapy in stage ii colon cancer and ctdna
-
6:58
personalizing ctdna analysis to predict crc relapse
-
12:01
debate: is circulating tumor dna ready to guide adjuvant therapy in colon cancer? - yes
-
3:16
the utility of ctdna in colorectal cancer management
-
1:09
treatment of crc in adjuvant setting
-
8:04
“circulate” clinical trial evaluating ctdna dynamics and clinical outcomes in colon cancer
-
0:44
ctdna and immunoscore as prognostic markers in stage iii colon cancer